Anne C. Toffart
Grenoble, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Rebiopsy Feasibility and Clinical Impact on Metastatic Non-Small-Cell Lung Cancer With EGFR/ALK/ROS Oncogenic Driver Progression After Optimal Targeted Therapy: A Multicenter Real-World Analysis.
Journal: Clinical lung cancer
Published: April 21, 2025
Real-world efficacy and safety of amivantamab in EGFR exon-20-mutant non-small cell lung cancer in a French early-access program: Amexon 20 GFPC study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 19, 2025
Compassionate Access to Brigatinib for Patients with Non-small-cell Lung Cancer Harboring a ROS1 Rearrangement: Results from the BRIGAROS Study.
Journal: Targeted oncology
Published: February 03, 2025
Efficacy of Plasmapheresis in Nivolumab-Associated ANCA Glomerulonephritis: A Case Report and Pathophysiology Discussion.
Journal: Case reports in nephrology and dialysis
Published: April 10, 2021
Immune Checkpoint Inhibitors Rechallenge Efficacy in Non-Small-Cell Lung Cancer Patients.
Journal: Clinical lung cancer
Published: January 30, 2020
A Brief Report of Transformation From NSCLC to SCLC: Molecular and Therapeutic Characteristics.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 23, 2018
Giant sternal condrosarcoma.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 17, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026